Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 1, 2015, Pages 21-30

  Gnatiuc, L ^a,m   Buist, A S ^b,l   Kato, B ^a,m   Janson, C ^c   Ait Khaled N ^d   Nielsen, R ^e,f   Koul, P A ^g   Nizankowska Mogilnicka, E ^h   Obaseki, D ^i,ae   Idolor, L F ^j,v,ab   Harrabi, I ^k   Burney, P G J ^a,m   Vollmer, W ^l   Gillespie, S ^l   McBurnie, M ^l   Jithoo, A ^m,q   Coton, S ^m   Azhar, H ^m   Zhong, N S ⁿ   Liu, S M ⁿ   Lu, J C ⁿ   Ran, P X ⁿ   Wang, D L ⁿ   Zheng, J P ⁿ   Zhou, Y M ⁿ   Kocabas, A ^o   Hancioglu, A ^o   Hanta, I ^o   Kuleci, S ^o   Turkyilmaz, A S ^o   Umut, S ^o   Unalan, T ^o   Studnicka, M ^p   Dawes, T ^p   Lamprecht, B ^p   Schirhofer, L ^p   Bateman, E ^q   Adams, D ^q   Barnes, E ^q   Freeman, J ^q   Hayes, A ^q   Hlengwa, S ^q   Johannisen, C ^q   Koopman, M ^q   Louw, I ^q   Ludick, I ^q   Olckers, A ^q   Ryck, J ^q   Storbeck, J ^q   Gislason, T ^r   Benedikdtsdottir, B ^r   Jorundsdottir, K ^r   Gudmundsdottir, L ^r   Gudmundsdottir, S ^r   Gundmundsson, G ^r   Frey, J ^h   Harat, R ^h   Mejza, F ^h   Nastalek, P ^h   Pajak, A ^h   Skucha, W ^h   Szczeklik, A ^h   Twardowska, M ^h   Welte, T ^s   Bodemann, I ^s   Geldmacher, H ^s   Schweda Linow, A ^s   Gulsvik, A ^e   Endresen, T ^e   Svendsen, L ^e   Tan, W C ^t   Wang, W ^t   Mannino, D M ^u   Cain, J ^u   Copeland, R ^u   Hazen, D ^u   Methvin, J ^u   Dantes, R B ^v   Amarillo, L ^v   Berratio, L U ^v   Fernandez, L C ^v   Francisco, N A ^v,ab   Garcia, G S ^v   De Guia, T S ^v,ab   Naval, S S ^v   Reyes, T ^v   Roa, C C ^v,ab   Sanchez, Ma F ^v   Simpao, L P ^v   Jenkins, C ^w   Marks, G ^w   Bird, T ^w   Espinel, P ^w   Hardaker, K ^w   Toelle, B ^w   Amor, C ^a   Potts, J ^a   Tumilty, M ^a   McLean, F ^a   Wouters, E F M ^x   Wesseling, G J ^x   Barbara, C ^y   Rodrigues, F ^y   Dias, H ^y   Cardoso, J ^y   Almeida, J ^y   Matos, M J ^y   Simao, P ^y   Santos, M ^y   Ferreira, R ^y   Olafsdottir, I S ^c   Nisser, K ^c   Spetz Nystrom U ^c   Hagg G ^c   Lund, G M ^c   Jogi R ^z   Laja, H ^z   Ulst, K ^z   Zobel, V ^z   Lill, T J ^z   Malik, S ^g   Hakim, N A ^g   Khan, U H ^g   Chowgule, R ^aa   Shetye, V ^aa   Raphael, J ^aa   Almeda, R ^aa   Tawde, M ^aa   Tadvi, R ^aa   Katkar, S ^aa   Kadam, M ^aa   Dhanawade, R ^aa   Ghurup, U ^aa   Denguezli, M ^k   Tabka, Z ^k   Daldoul, H ^k   Boukheroufa, Z ^k   Chouikha, F ^k   Khalifa, W B ^k   Ayuyao, F G ^ab   Tady, C Z ^ab   Tan, D T ^ab   Banal Yang, S ^ab   Balanag, V M ^ab   Reyes, M T N ^ab   Dantes, Renato B ^ab   Salvi, S ^ac   Hirve, S ^ac   Brashier, B ^ac   Londhe, J ^ac   Madas, S ^ac   Sambhudas, S ^ac   Chaidhary, B ^ac   Tambe, M ^ac   Pingale, S ^ac   Umap, A ^ac   Shelar, N ^ac   Devchakke, S ^ac   Chaudhary, S ^ac   Bondre, S ^ac   Walke, S ^ac   Gawhane, A ^ac   Sapkal, A ^ac   Argade, R ^ac   Gaikwad, V ^ac   Benjelloun, M C ^ad   Nejjari, C ^ad   Elbiaze, M ^ad   El Rhazi, K ^ad   Erhabor, G ⁱ   Awopeju, O ⁱ   Adewole, O ⁱ   Crapo, R O ^ae   Jensen, R L ^ae   Enright, P ^af   Harnoncourt, G ^ag   Hooper, R ^m   more..

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e UNIVERSITY OF BERGEN   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^j Lung Centre of the Philippines   (Philippines)

^k UNIVERSITY OF SOUSSE   (Tunisia)

^l BOLD Co Ordinating Centre Kaiser Permanente   (United States)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ GUANGZHOU MEDICAL UNIVERSITY   (China)

^o CUKUROVA UNIVERSITY   (Turkey)

^p PARACELSUS MEDICAL UNIVERSITY   (Austria)

^q UNIVERSITY OF CAPE TOWN   (South Africa)

^r LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^s HANNOVER MEDICAL SCHOOL   (Germany)

^t UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^u UNIVERSITY OF KENTUCKY   (United States)

^v Philippine College of Chest Physicians   (Philippines)

^w Woolcock Institute of Medical Research   (Australia)

^x MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^y Portuguese Society of Paediatrics   (Portugal)

^z TARTU UNIVERSITY HOSPITAL   (Estonia)

^aa Indian Institute of Environmental Medicine   (India)

^ab PHILIPPINE GENERAL HOSPITAL   (Philippines)

^ac KEM HOSPITAL   (India)

^ad Laboratoire d'Epidémiologie Recherche Clinique et Santé Communautaire   (Morocco)

^ae LDS HOSPITAL   (United States)

^af UNIVERSITY OF ARIZONA   (United States)

^ag ndd Medizintechnik AG   (Switzerland)

more..

Author keywords

Copd and asthma treatments; Determinants for use; Essential respiratory medications; Prevention of exacerbations

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; RESPIRATORY TRACT AGENT; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG USE; ECONOMIC ASPECT; HEALTH CARE ACCESS; HUMAN; LOWEST INCOME GROUP; PREDICTION; PREVALENCE; RESPIRATORY TRACT DISEASE; AGED; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; POVERTY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADRENAL CORTEX HORMONES; AGED; ASTHMA; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; POVERTY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; VACCINATION;

EID: 84918793208     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0263     Document Type: Article

References (27)

1. Jafarov A, Schneider T, Waning B, et al. Comparative table of core and complementary medicines on the WHO Essential Medicines List from 1977-2011. Geneva, Switzerland: WHO, 2011. http://www.who.int/medicines/publications/essentialmedicines/en/index.html Accessed October 2014.
2. Laing R, Waning B, Gray A, Ford N, 't Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003;361:1723-1729.
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, USA: National Institutes of Health, GOLD, 2011. http://www.goldcopd.org/uploads/users/files/GOLD2011-Summary.pdf Accessed October 2014.
4. The Global Initiative for Asthma. Pocket guide for asthma management and prevention. Bethesda, MD, USA: National Institutes of Health, GOLD, 2012. http://www.ginasthma.org/uploads/users/files/GINA%20Pocket%20Guide%202012-wms.pdf Accessed October 2014.
5. Aït-Khaled N, Auregan G, Bencharif N, et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000;4:268-271.
6. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007;85:279-288.
7. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009;373:240-249.
8. Babar Z U D, Lessing C, Mace C, Bissell K. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. PharmacoEconomics 2013;31:1063-1082.
9. Poole P, Chacko E E, Wood-Baker R, Cates C J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (1): CD002733. Review.
10. Cates C J, Jefferson T O, Rowe B H. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2008; (2): CD000364.
11. Santos-Sancho J M, Jimenez-Trujillo I, Hernández-Barrera V, et al. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother 2012;8:938-945.
12. Bali N K, Ashraf M, Ahmad F, et al. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India. Influenza Other Respir Viruses 2013;7:540-545.
13. Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2:277-283.
14. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159:179-187.
15. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, USA: National Institutes of Health, GOLD, 2008. http://www.goldcopd.org Accessed October 2014.
16. Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
17. Cazzola M, MacNee W, Martinez F J, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-469.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
19. Higgins J P, Thompson S G, Deeks J J, Altman D G. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
20. World Bank. World Development Indicators Database. Gross National Income per capita indicators (Atlas method, International current US$, 2010). Washington DC, USA: World Bank, 2014. http://data.worldbank.org/indicator/NY. GNP. PCAP. CD Accessed October 2014.
21. Burney P, Potts J, Aït-Khaled N, et al. A multinational study of treatment failures in asthma management. Int J Tuberc Lung Dis 2008;12:13-18.
22. International Union Against Tuberculosis and Lung Disease. Global asthma report, 2011. Paris, France: The Union, 2011. http://www.globalasthmareport.org/Accessed October 2014.
23. The Norwegian Directorate of Health. Nasjonal faglig retningslinje og veileder for diagnostisering og oppfølgning av personer med kols. Oslo, Norway: Helsedirektoratet, 2012. http://www.helsedirektoratet.no/publikasjoner/nasjonal-fagligretningslinje-og-veileder-for-forebygging-diagnostisering-ogoppfolging-av-personer-med-kols/Sider/default.aspx Accessed October 2014.
24. Nielsen R, Johannessen A, Benediktsdottir B, et al. Present and future costs of COPD in Iceland and Norway: Results from the BOLD study. Eur Respir J 2009;34:850-857.
25. Koppel A, Kahur K, Habicht T, Saar P, Habicht J, van Ginneken E. Estonia: health system review. Health Syst Transit 2008;10:1-230.
26. Koul P A. Managing chronic diseases: combination of inhaler treatment in India has shown good results. BMJ 2005;330:964.
27. Jawla S, Gupta A K, Singla R, Gupta V. General awareness and relative popularity of allopathic, ayurvedic and homeopathic systems. J Chem Pharmaceutical Res 2009;1:105-111.